CareRx Corporation
CRRX.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 65.85M | 68.07M | 67.21M | 66.55M | 66.96M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 65.85M | 68.07M | 67.21M | 66.55M | 66.96M |
| Cost of Revenue | 46.32M | 48.25M | 47.28M | 46.96M | 48.09M |
| Gross Profit | 19.53M | 19.82M | 19.93M | 19.60M | 18.87M |
| SG&A Expenses | 19.37M | 17.91M | 18.61M | 18.01M | 17.48M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 65.69M | 66.16M | 65.89M | 64.96M | 65.56M |
| Operating Income | 161.40K | 1.91M | 1.32M | 1.59M | 1.40M |
| Income Before Tax | -1.58M | -263.90K | -1.01M | -383.50K | -2.85M |
| Income Tax Expenses | 22.90K | -- | -- | -- | -127.20K |
| Earnings from Continuing Operations | -1.60M | -263.90K | -1.01M | -383.50K | -2.72M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.60M | -263.90K | -1.01M | -383.50K | -2.72M |
| EBIT | 161.40K | 1.91M | 1.32M | 1.59M | 1.40M |
| EBITDA | 785.10K | 6.77M | 4.16M | 4.47M | 2.16M |
| EPS Basic | -0.03 | 0.00 | -0.02 | -0.01 | -0.05 |
| Normalized Basic EPS | -0.01 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted | -0.03 | 0.00 | -0.02 | -0.01 | -0.05 |
| Normalized Diluted EPS | -0.01 | 0.00 | 0.00 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 60.93M | 60.09M | 60.13M | 59.86M | 58.65M |
| Average Diluted Shares Outstanding | 60.93M | 60.09M | 60.13M | 59.86M | 58.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |